nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0997	0.332	CbGbCtD
Avanafil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0927	0.308	CbGbCtD
Avanafil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0426	0.142	CbGbCtD
Avanafil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.039	0.13	CbGbCtD
Avanafil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0266	0.0885	CbGbCtD
Avanafil—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000983	0.0014	CcSEcCtD
Avanafil—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000983	0.0014	CcSEcCtD
Avanafil—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000981	0.0014	CcSEcCtD
Avanafil—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000979	0.0014	CcSEcCtD
Avanafil—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000977	0.0014	CcSEcCtD
Avanafil—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00097	0.00139	CcSEcCtD
Avanafil—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00097	0.00139	CcSEcCtD
Avanafil—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000969	0.00139	CcSEcCtD
Avanafil—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000969	0.00139	CcSEcCtD
Avanafil—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000965	0.00138	CcSEcCtD
Avanafil—Back pain—Etoposide—peripheral nervous system neoplasm	0.00096	0.00137	CcSEcCtD
Avanafil—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000957	0.00137	CcSEcCtD
Avanafil—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000955	0.00136	CcSEcCtD
Avanafil—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000947	0.00135	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000946	0.00135	CcSEcCtD
Avanafil—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000945	0.00135	CcSEcCtD
Avanafil—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000939	0.00134	CcSEcCtD
Avanafil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000937	0.00134	CcSEcCtD
Avanafil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000937	0.00134	CcSEcCtD
Avanafil—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000935	0.00134	CcSEcCtD
Avanafil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000925	0.00132	CcSEcCtD
Avanafil—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000924	0.00132	CcSEcCtD
Avanafil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000923	0.00132	CcSEcCtD
Avanafil—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000923	0.00132	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000916	0.00131	CcSEcCtD
Avanafil—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.00131	CcSEcCtD
Avanafil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000914	0.00131	CcSEcCtD
Avanafil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000913	0.00131	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000911	0.0013	CcSEcCtD
Avanafil—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000906	0.0013	CcSEcCtD
Avanafil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000906	0.00129	CcSEcCtD
Avanafil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000906	0.00129	CcSEcCtD
Avanafil—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000905	0.00129	CcSEcCtD
Avanafil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000896	0.00128	CcSEcCtD
Avanafil—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000895	0.00128	CcSEcCtD
Avanafil—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000892	0.00128	CcSEcCtD
Avanafil—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000888	0.00127	CcSEcCtD
Avanafil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000885	0.00127	CcSEcCtD
Avanafil—Infection—Cisplatin—peripheral nervous system neoplasm	0.000879	0.00126	CcSEcCtD
Avanafil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000878	0.00125	CcSEcCtD
Avanafil—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000876	0.00125	CcSEcCtD
Avanafil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00124	CcSEcCtD
Avanafil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00124	CcSEcCtD
Avanafil—Rash—Topotecan—peripheral nervous system neoplasm	0.000871	0.00124	CcSEcCtD
Avanafil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00087	0.00124	CcSEcCtD
Avanafil—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000867	0.00124	CcSEcCtD
Avanafil—Cough—Etoposide—peripheral nervous system neoplasm	0.000866	0.00124	CcSEcCtD
Avanafil—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000866	0.00124	CcSEcCtD
Avanafil—Headache—Topotecan—peripheral nervous system neoplasm	0.000865	0.00124	CcSEcCtD
Avanafil—Rash—Tretinoin—peripheral nervous system neoplasm	0.000864	0.00123	CcSEcCtD
Avanafil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000864	0.00123	CcSEcCtD
Avanafil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000864	0.00123	CcSEcCtD
Avanafil—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000863	0.00123	CcSEcCtD
Avanafil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.00123	CcSEcCtD
Avanafil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000863	0.00123	CcSEcCtD
Avanafil—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000862	0.00123	CcSEcCtD
Avanafil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00086	0.00123	CcSEcCtD
Avanafil—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000859	0.00123	CcSEcCtD
Avanafil—Headache—Tretinoin—peripheral nervous system neoplasm	0.000858	0.00123	CcSEcCtD
Avanafil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000858	0.00123	CcSEcCtD
Avanafil—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000857	0.00123	CcSEcCtD
Avanafil—Constipation—Vincristine—peripheral nervous system neoplasm	0.000855	0.00122	CcSEcCtD
Avanafil—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.00122	CcSEcCtD
Avanafil—Rash—Melphalan—peripheral nervous system neoplasm	0.000852	0.00122	CcSEcCtD
Avanafil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000852	0.00122	CcSEcCtD
Avanafil—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000845	0.00121	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000839	0.0012	CcSEcCtD
Avanafil—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000835	0.00119	CcSEcCtD
Avanafil—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000826	0.00118	CcSEcCtD
Avanafil—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000826	0.00118	CcSEcCtD
Avanafil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.00117	CcSEcCtD
Avanafil—Nausea—Topotecan—peripheral nervous system neoplasm	0.00082	0.00117	CcSEcCtD
Avanafil—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000818	0.00117	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000815	0.00117	CcSEcCtD
Avanafil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000814	0.00116	CcSEcCtD
Avanafil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000814	0.00116	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000806	0.00115	CcSEcCtD
Avanafil—Infection—Etoposide—peripheral nervous system neoplasm	0.000805	0.00115	CcSEcCtD
Avanafil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000803	0.00115	CcSEcCtD
Avanafil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000803	0.00115	CcSEcCtD
Avanafil—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000801	0.00115	CcSEcCtD
Avanafil—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000799	0.00114	CcSEcCtD
Avanafil—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000791	0.00113	CcSEcCtD
Avanafil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000791	0.00113	CcSEcCtD
Avanafil—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000787	0.00113	CcSEcCtD
Avanafil—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000778	0.00111	CcSEcCtD
Avanafil—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000773	0.0011	CcSEcCtD
Avanafil—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000768	0.0011	CcSEcCtD
Avanafil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000766	0.0011	CcSEcCtD
Avanafil—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.00109	CcSEcCtD
Avanafil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000764	0.00109	CcSEcCtD
Avanafil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000757	0.00108	CcSEcCtD
Avanafil—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000757	0.00108	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000754	0.00108	CcSEcCtD
Avanafil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.00106	CcSEcCtD
Avanafil—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000742	0.00106	CcSEcCtD
Avanafil—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.00106	CcSEcCtD
Avanafil—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000738	0.00105	CcSEcCtD
Avanafil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000734	0.00105	CcSEcCtD
Avanafil—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000727	0.00104	CcSEcCtD
Avanafil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00072	0.00103	CcSEcCtD
Avanafil—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00072	0.00103	CcSEcCtD
Avanafil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000718	0.00103	CcSEcCtD
Avanafil—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000712	0.00102	CcSEcCtD
Avanafil—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000712	0.00102	CcSEcCtD
Avanafil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.00102	CcSEcCtD
Avanafil—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.00102	CcSEcCtD
Avanafil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.00102	CcSEcCtD
Avanafil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000706	0.00101	CcSEcCtD
Avanafil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0007	0.001	CcSEcCtD
Avanafil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000699	0.000999	CcSEcCtD
Avanafil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000699	0.000999	CcSEcCtD
Avanafil—Constipation—Etoposide—peripheral nervous system neoplasm	0.000693	0.000991	CcSEcCtD
Avanafil—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000692	0.00099	CcSEcCtD
Avanafil—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.000982	CcSEcCtD
Avanafil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.000981	CcSEcCtD
Avanafil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000684	0.000978	CcSEcCtD
Avanafil—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000976	CcSEcCtD
Avanafil—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000971	CcSEcCtD
Avanafil—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.000961	CcSEcCtD
Avanafil—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000672	0.00096	CcSEcCtD
Avanafil—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000955	CcSEcCtD
Avanafil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000665	0.000951	CcSEcCtD
Avanafil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000661	0.000946	CcSEcCtD
Avanafil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.000943	CcSEcCtD
Avanafil—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000942	CcSEcCtD
Avanafil—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000942	CcSEcCtD
Avanafil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.000936	CcSEcCtD
Avanafil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.000935	CcSEcCtD
Avanafil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00065	0.00093	CcSEcCtD
Avanafil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000641	0.000916	CcSEcCtD
Avanafil—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000916	CcSEcCtD
Avanafil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000636	0.000909	CcSEcCtD
Avanafil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000635	0.000907	CcSEcCtD
Avanafil—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000631	0.000903	CcSEcCtD
Avanafil—Rash—Vincristine—peripheral nervous system neoplasm	0.000631	0.000902	CcSEcCtD
Avanafil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00063	0.000901	CcSEcCtD
Avanafil—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00063	0.0009	CcSEcCtD
Avanafil—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000898	CcSEcCtD
Avanafil—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000628	0.000898	CcSEcCtD
Avanafil—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000627	0.000896	CcSEcCtD
Avanafil—Headache—Vincristine—peripheral nervous system neoplasm	0.000627	0.000896	CcSEcCtD
Avanafil—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000888	CcSEcCtD
Avanafil—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.000884	CcSEcCtD
Avanafil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.000881	CcSEcCtD
Avanafil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000865	CcSEcCtD
Avanafil—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000597	0.000854	CcSEcCtD
Avanafil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000594	0.000849	CcSEcCtD
Avanafil—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000848	CcSEcCtD
Avanafil—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000848	CcSEcCtD
Avanafil—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000584	0.000835	CcSEcCtD
Avanafil—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000833	CcSEcCtD
Avanafil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000581	0.000831	CcSEcCtD
Avanafil—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.000831	CcSEcCtD
Avanafil—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000829	CcSEcCtD
Avanafil—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.000829	CcSEcCtD
Avanafil—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000825	CcSEcCtD
Avanafil—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000576	0.000824	CcSEcCtD
Avanafil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000573	0.000819	CcSEcCtD
Avanafil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000562	0.000804	CcSEcCtD
Avanafil—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00056	0.000801	CcSEcCtD
Avanafil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000797	CcSEcCtD
Avanafil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000557	0.000796	CcSEcCtD
Avanafil—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000796	CcSEcCtD
Avanafil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000554	0.000793	CcSEcCtD
Avanafil—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000553	0.00079	CcSEcCtD
Avanafil—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000785	CcSEcCtD
Avanafil—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000785	CcSEcCtD
Avanafil—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000538	0.00077	CcSEcCtD
Avanafil—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000767	CcSEcCtD
Avanafil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000536	0.000766	CcSEcCtD
Avanafil—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000765	CcSEcCtD
Avanafil—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000764	CcSEcCtD
Avanafil—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.000762	CcSEcCtD
Avanafil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000525	0.000751	CcSEcCtD
Avanafil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000524	0.00075	CcSEcCtD
Avanafil—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000741	CcSEcCtD
Avanafil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000515	0.000736	CcSEcCtD
Avanafil—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000736	CcSEcCtD
Avanafil—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000511	0.000731	CcSEcCtD
Avanafil—Rash—Etoposide—peripheral nervous system neoplasm	0.000511	0.00073	CcSEcCtD
Avanafil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00051	0.00073	CcSEcCtD
Avanafil—Headache—Etoposide—peripheral nervous system neoplasm	0.000508	0.000726	CcSEcCtD
Avanafil—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000715	CcSEcCtD
Avanafil—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000712	CcSEcCtD
Avanafil—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000708	CcSEcCtD
Avanafil—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000703	CcSEcCtD
Avanafil—Cough—Epirubicin—peripheral nervous system neoplasm	0.000486	0.000694	CcSEcCtD
Avanafil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000694	CcSEcCtD
Avanafil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000481	0.000688	CcSEcCtD
Avanafil—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000687	CcSEcCtD
Avanafil—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000677	CcSEcCtD
Avanafil—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000677	CcSEcCtD
Avanafil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000677	CcSEcCtD
Avanafil—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.000676	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000673	CcSEcCtD
Avanafil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000662	CcSEcCtD
Avanafil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000661	CcSEcCtD
Avanafil—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000651	CcSEcCtD
Avanafil—Infection—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000645	CcSEcCtD
Avanafil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000642	CcSEcCtD
Avanafil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000637	CcSEcCtD
Avanafil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000636	CcSEcCtD
Avanafil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000634	CcSEcCtD
Avanafil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000631	CcSEcCtD
Avanafil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000627	CcSEcCtD
Avanafil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000627	CcSEcCtD
Avanafil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000627	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000622	CcSEcCtD
Avanafil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000613	CcSEcCtD
Avanafil—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000607	CcSEcCtD
Avanafil—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000597	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000592	CcSEcCtD
Avanafil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000589	CcSEcCtD
Avanafil—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000587	CcSEcCtD
Avanafil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000586	CcSEcCtD
Avanafil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000584	CcSEcCtD
Avanafil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000577	CcSEcCtD
Avanafil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000572	CcSEcCtD
Avanafil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000561	CcSEcCtD
Avanafil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000561	CcSEcCtD
Avanafil—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000392	0.00056	CcSEcCtD
Avanafil—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000555	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000547	CcSEcCtD
Avanafil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000543	CcSEcCtD
Avanafil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000534	CcSEcCtD
Avanafil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000529	CcSEcCtD
Avanafil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000519	CcSEcCtD
Avanafil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000518	CcSEcCtD
Avanafil—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000514	CcSEcCtD
Avanafil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000513	CcSEcCtD
Avanafil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000475	CcSEcCtD
Avanafil—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000466	CcSEcCtD
Avanafil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000459	CcSEcCtD
Avanafil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000444	CcSEcCtD
Avanafil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000431	CcSEcCtD
Avanafil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000429	CcSEcCtD
Avanafil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000425	CcSEcCtD
Avanafil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000413	CcSEcCtD
Avanafil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000411	CcSEcCtD
Avanafil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000409	CcSEcCtD
Avanafil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000409	CcSEcCtD
Avanafil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000407	CcSEcCtD
Avanafil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000397	CcSEcCtD
Avanafil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000386	CcSEcCtD
Avanafil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000382	CcSEcCtD
Avanafil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000379	CcSEcCtD
Avanafil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000378	CcSEcCtD
Avanafil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000376	CcSEcCtD
Avanafil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000357	CcSEcCtD
